Nautilus Biotechnology Inc (NAS:NAUT)
$ 2.36 +0.035 (+1.51%) Market Cap: 299.91 Mil Enterprise Value: 232.91 Mil PE Ratio: 0 PB Ratio: 2.07 GF Score: 28/100

Nautilus Biotechnology Inc at TD Cowen Healthcare Conference Transcript

Mar 2, 2026 / 03:30 PM GMT
Release Date Price: $2.32 (-4.13%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NAUT.OQ - Nautilus Biotechnology Inc
Nautilus Biotechnology Inc at TD Cowen Healthcare Conference
Mar 02, 2026 / 03:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning. Dan Brennan, TD TD Cow and Life Science Tools and diagnostics analyst, day one of the forty-sixth, annual TD Cow and Healthcare Conference. Pleased to be joined here on the stage with, co-founder and CEO of Nautilus, Sujal Patel. So Su Joel, welcome and thank you.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thanks, Dan, and I appreciate the invite to the conference.

--------------------------------------------------------------------------------
Unidentified_1 [3]
----------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot